@FierceBiotech: Analysts fret as market turbulence threatens biotech IPO market. Article | Follow @FierceBiotech
@JohnCFierce: Dumped by Roche, Constellation Pharma scrambles to join IPO queue. Report | Follow @JohnCFierce
> Germany's MorphoSys AG and Immatics Biotechnologies GmbH announced a strategic alliance to generate "novel antibody-based therapeutics against multiple proprietary cancer antigens recognized by T cells." Release
> Versant Ventures' incubator Highline Therapeutics is partnering with Weill Cornell Medical College to spin out some new biotechs in New York City. Release
> The FDA has accepted Epizyme's ($EPZM) IND for tazemetostat, a new drug for INI1-negative tumors or synovial sarcoma. Release
Medical Device News
@FierceMedDev: ICYMI: Roche's M&A party rages on with Kapa Biosystems deal. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: Bayer's Grants4Apps accelerator funds its second crop of digital health startups. Article | Follow @VarunSaxena2
@EmilyWFierce: Bristol-Myers, Sanofi catch a break in Plavix marketing case. FiercePharma story | Follow @EmilyWFierce
> WSJ: Debate roils over new radiation technique for breast cancer. More
> FDA approves first self-contained, mobile continuous blood glucose monitor from Dexcom. Article
Pharma News
@FiercePharma: India's Dr. Reddy's widens strategies to move beyond basic generics. FiercePharmaAsia story | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: Mylan recalls more of the cancer meds made at Indian plants hit with FDA warning letter. Story | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Analysts: Gilead's hep C scripts keep slowing, and Q3 sales forecasts should too. More | Follow @CarlyHFierce
> Shire rejigs manufacturing deal to step up Cinryze production. Story
> Bristol-Myers, Sanofi catch a break in Plavix marketing case. Article
> Bass failed at challenging Acorda's patents. Can pharma rest easy now? More
Drug Delivery News
> India's NIPER boasts new dry crystallization method to join growing delivery market. Article
> Benitec IPO swoons amid market rout, but other drug delivery focused players still trying to debut. More
> Former Unilife employee admits that his whistleblower suit lacked merit in legal settlement. Report
> Copper naturally assembles in bio component to make stable, scalable delivery structures. Story
> Study finds novel, rectal drug delivery catheter is useful in emergency settings. Article
Pharma Manufacturing News
> China-based biotech to build manufacturing plant in Suzhou. More
> Zoetis expands Nebraska facility even as its plots 10 plant closings. Story
> GSK expanding OTC plant that had been slated for sale. Report
> Peptide maker to triple site with $18.8M project. Article
> New compounding pharmacy company backed by Bain. Item
Pharma Asia News
> China slowdown for pharma shouldn't be ignored, WSJ says. Story
> Stem cell laws in Japan a magnet for research, Nikkei says. More
> India's Dr. Reddy's widens strategies to move beyond basic generics. Report
> Samsung Bioepis on track for $1B U.S. listing next year for biosimilar powerhouse. Story
> BeiGene plans wider footprint in China with Suzhou development site. Article